Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

An Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

ClinicalTrials.gov ID: NCT01703923

Public ClinicalTrials.gov record NCT01703923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 3:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory, Randomized, Placebo-Controlled, Double-Blind, Crossover Study of FP01 Lozenges in Subjects With Chronic Refractory Cough

Study identification

NCT ID
NCT01703923
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Avalo Therapeutics, Inc.
Industry
Enrollment
83 participants

Conditions and interventions

Interventions

  • FP01 Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2012
Primary completion
Aug 31, 2013
Completion
Aug 31, 2013
Last update posted
Nov 4, 2014

2012 – 2013

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Allergy & Asthma Associates of Santa Clara Valley San Jose California 95117
Sher Allergy Specialists Largo Florida 33778
South Florida Clinical Research Trials, LLC Miami Florida 33186
American Health Research Charlotte North Carolina 28207
Wake Research, LLC Raleigh North Carolina 27612
Oklahoma Institute of Allergy and Asthma Oklahoma City Oklahoma 73131
Allergy, Asthma and Immunology Center, P.C./ Vital Prospects Clinical Research Institute, P.C. Tulsa Oklahoma 74136
Bellingham Asthma and Allergy Associates Bellingham Washington 98225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01703923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2014 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01703923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →